NCT01063010View on ClinicalTrials.gov

Pilot Study of Bevacizumab (Avastin) in Patients With Septic Shock

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

February 28, 2010

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Septic Shock
Interventions
DRUG

Bevacizumab

Administered intravenously 10 mg/kg over 90 minutes (+ 15 minutes)

DRUG

Placebo

Placebo administered intravenously for 90 minutes (+ 15 minutes)

Trial Locations (3)

28203

Carolinas Medical Center, Charlotte

02215

Beth Israel Medical Center, Boston

08103

Cooper University Hospital, Camden

Sponsors

Collaborators (1)

Carolinas Medical Center
All Listed Sponsors
collaborator

The Cooper Health System

OTHER

collaborator

Carolinas Medical Center

OTHER

lead

Beth Israel Deaconess Medical Center

OTHER